[Form 4] AXON ENTERPRISE, INC. Insider Trading Activity

Rhea-AI Filing Summary

Axon Enterprise, Inc. (AXON) reported that its Chief Executive Officer and director received 97,015 shares of common stock on 11/13/2025 through performance-based restricted stock units tied to tranche 3 of the 2024 CEO Performance Award. The Compensation Committee certified that the performance conditions were achieved on that date, triggering the award. These units are scheduled to vest on December 31, 2029, subject to the CEO’s continued employment. After this transaction, the CEO beneficially owns 3,120,997 shares of Axon common stock directly. Vested shares from each tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, other than shares withheld for taxes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH PATRICK W

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A(1)		97,015	A	$0	3,120,997	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction consists of performance-based restricted stock units granted on December 22, 2023, for the achievement of tranche 3 of the 2024 CEO Performance Award, for which the performance conditions were determined to have been certified by the Compensation Committee on the transaction date. The units will vest on December 31, 2029, subject to continued employment through such date. Following the vesting of each tranche, the shares applicable to each tranche are subject to a minimum holding period from the vesting date until the earlier of (i) December 31, 2030 and (ii) the date that a subsequent tranche vests, excluding shares that are withheld to cover taxes.

Remarks:

	/s/ Patrick W. Smith by Isaiah Fields, Attorney-in-Fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Axon (AXON) report in this Form 4 filing?

Axon Enterprise reported that its Chief Executive Officer acquired 97,015 shares of common stock on 11/13/2025 through performance-based restricted stock units from the 2024 CEO Performance Award.

Who is the reporting person in the Axon (AXON) Form 4 and what is their role?

The reporting person is Patrick W. Smith, who serves as both a Director and the Chief Executive Officer of Axon Enterprise, Inc.

How many Axon (AXON) shares does the CEO own after the reported transaction?

Following the reported transaction, the CEO beneficially owns 3,120,997 shares of Axon common stock, held in direct ownership.

What are the vesting terms for the 97,015 performance-based RSUs reported by Axon (AXON)?

The 97,015 performance-based restricted stock units are scheduled to vest on December 31, 2029, provided the CEO remains employed with Axon through that date.

Are there any holding requirements on the vested Axon (AXON) shares from this CEO award?

After each tranche vests, the related shares must be held until the earlier of December 31, 2030 or the date a subsequent tranche vests, except for shares withheld to cover taxes.

What performance conditions were tied to the Axon (AXON) CEO’s 2024 Performance Award tranche?

The award reflects tranche 3 of the 2024 CEO Performance Award. The Compensation Committee determined the performance conditions were certified as achieved on 11/13/2025, triggering the grant of 97,015 units.